By
COPENHAGEN: Danish pharmaceutical giant and weight loss drugmaker Novo Nordisk said Thursday net profit had risen by 28 percent in the first quarter.
Pharma Bureau seeks ‘CPI-adjusted’ prices for medicines
A company statement said net profit stood at 25.4 billion kroner (3.4 billion euros) while turnover rose 28 percent to 65.3 billion kroner.
More Stories





















Comments
Comments are closed for this article.